Increasing incidence of late-onset anti–AChR antibody–seropositive myasthenia gravis
- 27 September 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 65 (6), 928-930
- https://doi.org/10.1212/01.wnl.0000176067.32186.a3
Abstract
The incidence of myasthenia gravis (MG) from 1970 through 1999 was studied in an area with 2.3 million inhabitants. The mean annual incidence rate of early-onset MG was constant at 3.5 × 10-6. In late-onset MG, the rate increased from 4.7 to 20.8 × 10-6. The two onset types of MG may thus be distinct disorders. The author hypothesized that late-onset nonthymoma anti–acetylcholine receptor antibody–seropositive MG may be provoked by environmental factors.Keywords
This publication has 9 references indexed in Scilit:
- Evidence of underdiagnosis of myasthenia gravis in older peopleJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Myasthenia gravisNeurology, 2003
- The occurrence of anti-titin antibodies and thymomasNeurology, 2002
- Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodiesNeurology, 2001
- Epidemiology of seropositive myasthenia gravis in GreeceJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Late-Onset Myasthenia GravisArchives of Neurology, 1999
- Myasthenia gravis: a population based epidemiological study in Cambridgeshire, EnglandJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Drug‐induced Autoimmune Myasthenia GravisaAnnals of the New York Academy of Sciences, 1998
- Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population SurveyArchives of Neurology, 1991